Le Lézard
Classified in: Health
Subjects: PER, LGB, DEI

Charlie Health Appoints Ley Cray as Director of LGBTQIA+ Programming

BOZEMAN, Mont., Jan. 21, 2022 /PRNewswire/ -- Charlie Health, the first and only virtual mental health clinic for patients who need intensive mental health care, is excited to appoint Ley Cray as Director of LGBTQIA+ Programming. A trauma-informed yoga instructor, mindfulness coach, and certified philosophical consultant, Ley is on a mission to re-shape mental health care into an accessible, affirming practice for all young adults, with a specific focus on the needs of LGBTQIA+ youth. Ley joins the Charlie Health team at a critical moment, with recent research finding that LGBTQIA+ youth are almost five times as likely to have attempted suicide compared to non-LGBTQIA+ youth (source).

Beyond her role at Charlie Health, Cray teaches Trans Yoga and Queer Mindfulness classes and is co-founder of the Mind Body Ecology Institute. Cray received her Ph.D. in Philosophy at the Ohio State University and is currently pursuing her certification in Koru Mindfulness and Sexuality Counseling.

"As Charlie Health continues to expand, there's no one better to spearhead our LGBTQIA+ Programming than Ley," said Carter Barnhart, CEO and Co-Founder of Charlie Health. "She will be integral to innovating our mental health services for kids who need it most." In her new role, Cray will develop and lead therapy groups for Charlie Health patients (over half of whom are LGBTQIA+), their parents, and Charlie Health alumni. She'll also provide regular consultations for company staff on cutting-edge LGBTQIA+ concepts and care.

"The struggles of adolescents and young adults in LGBTQIA+ communities are real, and persistent lack of validation and proper mental health care is devastating. When our LGBTQIA+ youth seek help, they deserve the best, most compassionate care provided by the best, most knowledgeable providers," said Cray. "I'm honored to bring my expertise, lived experience, and passion to Charlie Health, leading and growing our services so that we may provide the most innovative, effective, and affirming care possible."

To learn more, visit www.charliehealth.com.

About Charlie Health
Charlie Health, founded in 2020, is the first and only virtual mental health clinic for high-acuity patients, enabling accessible care for millions. Charlie Health provides young people (11-28) struggling with mental health and substance use disorders personalized Intensive Outpatient (IOP) treatment programs consisting of group therapy, individual therapy, family therapy, and psychiatric support. By providing individualized, quality, and affordable mental health support, Charlie Health ensures that sustainable healing is available to all.

Press Inquiries: Alexis Ford, [email protected]

SOURCE Charlie Health

These press releases may also interest you

at 06:20
The "Infertility Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Infertility Treatment estimated at US$1.5 Billion in the year 2020, is...

at 06:15
The "Global Exosome Research Market by Product and Services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell, Dendritic Cell-derived), End-user, and Region -...

at 06:10
The "Global Peptide Cancer Vaccine Market Research Report 2022 (Status and Outlook)" report has been added to ResearchAndMarkets.com's offering. The Global Peptide Cancer Vaccine Market was estimated at USD 543.3 million in 2021 and is projected to...

at 06:05
NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of customers using Illumina...

at 06:05
BioAge Labs, Inc. ("BioAge", "the Company"), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that BioAge chief business officer (CBO) Peng Leong, PhD, MBA,...

at 06:05
Greenwich LifeSciences, Inc. (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced...

News published on 21 january 2022 at 09:06 and distributed by: